Mornex R, Peyrin L, Pagliari R, Cottet-Emard J M
Service d'Endocrinologie, Pavillon X, Hôpital Edouard Herriot, France.
Horm Res. 1991;36(5-6):220-6. doi: 10.1159/000182167.
Urinary methoxyamine determination is considered as the most sensitive and specific parameter for the diagnosis of pheochromocytoma. Since blood sampling is easier to perform, we developed a new HPLC method to assay metanephrine (MN) and normetanephrine (NMN) in plasma. We now report the results for total (free and conjugated) MN and NMN in 22 cases of pheochromocytoma compared to 26 healthy subjects, 33 patients with essential hypertension, 14 with miscellaneous diseases and 4 patients with renal failure. The mean normal values (mean +/- SD) were 0.40 +/- 0.10 ng/ml for MN and 0.85 +/- 0.25 ng/ml for NMN. The sum of MN+NMN was 1.25 +/- 0.28 and the range 0.9-1.9. In essential hypertension, the range of NMN+MN was 1.2-6.0. In the 4 renal failures, both MN and NMN were drastically increased. In 49 samples drawn from 22 pheochromocytomas, MN was elevated over the hypertensive range in 34 samples and NMN in 47 samples. The total MN+NMN ranged from 6.2 to 436 ng/ml; this figure was observed whatever the clinical presentation even in silent tumors or in paroxysmal forms between the crisis. After tumor removal, the values dropped rapidly. In conclusion, plasma determination of MN and NMN provides a highly sensitive and specific biological pointer for the diagnosis of pheochromocytoma in patients without renal failure.
尿甲氧基肾上腺素测定被认为是诊断嗜铬细胞瘤最敏感和特异的参数。由于采血更容易操作,我们开发了一种新的高效液相色谱法来测定血浆中的间甲肾上腺素(MN)和去甲间甲肾上腺素(NMN)。我们现在报告22例嗜铬细胞瘤患者与26名健康受试者、33例原发性高血压患者、14例患有其他疾病的患者以及4例肾衰竭患者的总(游离和结合)MN和NMN的检测结果。MN的平均正常值(平均值±标准差)为0.40±0.10 ng/ml,NMN为0.85±0.25 ng/ml。MN + NMN的总和为1.25±0.28,范围为0.9 - 1.9。在原发性高血压中,NMN + MN的范围为1.2 - 6.0。在4例肾衰竭患者中,MN和NMN均大幅升高。从22例嗜铬细胞瘤采集的49份样本中,34份样本中的MN高于高血压范围,47份样本中的NMN高于高血压范围。MN + NMN的总和范围为6.2至436 ng/ml;无论临床表现如何,即使是无症状肿瘤或发作间期的阵发性形式,均观察到该数值。肿瘤切除后,数值迅速下降。总之,对于无肾衰竭的患者,血浆中MN和NMN的测定为嗜铬细胞瘤的诊断提供了高度敏感和特异的生物学指标。